Source: International Congress 2014 – ERS/WHO joint Hot Topic "Tuberculosis (TB), tobacco and mobile phones" followed by the official launch of the ERS/WHO framework on TB elimination
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Followed by the official launch of the ERS/WHO framework on TB elimination. International Congress 2014 – ERS/WHO joint Hot Topic "Tuberculosis (TB), tobacco and mobile phones" followed by the official launch of the ERS/WHO framework on TB elimination

Member's Comments

No comment yet.

Related content which might interest you: Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community Source: Eur Respir J 2015; 45: 1760-1762 Year: 2015 Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe}, Source: Eur Respir J 2012; 40: 806-808 Year: 2012 Control of MDR-/XDR-TB and elimination of TB in Europe: status update Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation Year: 2012 Impact of applying the DOTS strategy on the TB endemic evolution in Bucharest Source: Eur Respir J 2007; 30: Suppl. 51, 422s Year: 2007 Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: Eur Respir J, 53 (1) 1802077; 10.1183/13993003.02077-2018 Year: 2019 The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Digital health technology for the end TB strategy: Developing priority products and making them work Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016 Answering the research gaps on MDR-TB in Europe: the results of the FP7 - funded TB PAN-NET project Source: Annual Congress 2012 - Fighting MDR- and XDR-TB in Europe: from programme results to research implementation Year: 2012 Implementation of national strategy in BA treatment in Russia Source: Eur Respir J 2006; 28: Suppl. 50, 54s Year: 2006 Implementation of national strategy in BA treatment in Russia Source: Eur Respir J 2005; 26: Suppl. 49, 277s Year: 2005 Implementation of national strategy in BA treatment in Russia Source: Eur Respir J 2004; 24: Suppl. 48, 501s Year: 2004 Implementation of national strategy in BA treatment in Russia Source: Eur Respir J 2003; 22: Suppl. 45, 420s Year: 2003 Public health guidance on programmatic management of latent tuberculosis infection in the European Union/European Economic Area Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection I Year: 2019 Digital health for the End TB Strategy: developing priority products and making them work Source: Eur Respir J 2016; 48: 29-45 Year: 2016 Evolution of the main indicators of the TB endemic 6 years after applying DOTS in the 4th sector of Bucharest Source: Eur Respir J 2007; 30: Suppl. 51, 519s Year: 2007 Latent TB infection: Patient choices and completion of treatment Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016